About Dharma Pharmaceuticals
Dharma Pharmaceuticals is a Consumer company based in Bristol (United States) founded in 2018 by Jack L Page, Shanna Berry, and Michael Johnson, and was acquired by GTI in May 2021. Cannabis-based medicinal products are manufactured in Bristol, United States. Its chief executive, as recorded, is Shanna Berry. Its focus areas include Healthcare and Cannabis Services.
Company details
Dharma Pharmaceuticals was established in 2018 and is based in Bristol, United States. Operations are conducted in the pharmaceuticals sector, with a focus on producing cannabis-derived products for medical applications. Manufacturing processes are centered on these items, which are developed to meet regulatory standards. The company is led by co-founders holding positions as CEO, COO, and CPO, overseeing product development and distribution.
- Headquarters Bristol, United States
- Founders Jack L Page, Shanna Berry, Michael Johnson
- Stage Acquired
- SectorsConsumer
- Email••••••••
- Phone•••• ••••
- Website dharmacann.com
- Acquired by GTI (May 2021)
Investors in Dharma Pharmaceuticals
Dharma Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include GTI Grows.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cannabis-related health and wellbeing products are provided nationally. | 2002 | gtigrows.com | Chicago, United States |
Investor details for Dharma Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dharma Pharmaceuticals
3 people are tracked at Dharma Pharmaceuticals (3 in leadership).
| Name | Role | Group |
|---|---|---|
Jack L Page | Co-Founder & COO | Leadership |
Shanna Berry | Co-Founder & CEO | Leadership |
Michael Johnson | Co-Founder & CPO | Leadership |
Complete people profiles for Dharma Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dharma Pharmaceuticals
2 dated milestones of Dharma Pharmaceuticals across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Dharma Pharmaceuticals is founded.
- Exit Acquired by GTI.
Top companies in Cannabis Platforms & Ecosystem Services
3 companies that operate in the same segment as Dharma Pharmaceuticals (Cannabis Platforms & Ecosystem Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Legal medical and recreational cannabis products are manufactured. | 2016 | Ann Arbor, Michigan, United States | USD 89.95 M | 214 | ||
Cannabis is cultivated, processed, and retailed by PharmaCann vertically. | 2014 | Oak Park, Illinois, United States | USD 218.7 M | 979 | ||
Consumer lawn and garden products and services are provided. | 1868 | Columbus, Ohio, United States | USD 3.41 B | 5,300 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dharma Pharmaceuticals
Dharma Pharmaceuticals was founded in 2018.
Dharma Pharmaceuticals is headquartered in Bristol, United States.
Shanna Berry is the CEO of Dharma Pharmaceuticals, as recorded in our data. They have also founded this company.
Dharma Pharmaceuticals was established in 2018 and is based in Bristol, United States. Operations are conducted in the pharmaceuticals sector, with a focus on producing cannabis-derived products for medical applications. Manufacturing processes are centered on these items, which are developed to meet regulatory standards. The company is led by co-founders holding positions as CEO, COO, and CPO, overseeing product development and distribution.
Dharma Pharmaceuticals has 1 investor. Key investors include GTI Grows.
Yes. Dharma Pharmaceuticals was acquired by GTI in May 2021.